Zha H - Search Results

1

Stroma-derived Fibrinogen-like Protein 2 Activates Cancer-associated Fibroblasts to Promote Tumor Growth in Lung Cancer.

Zhu Y, Zhang L, Zha H, Yang F, Hu C, Chen L, Guo B, Zhu B. Zhu Y, et al. Among authors: zha h. Int J Biol Sci. 2017 Jun 1;13(6):804-814. doi: 10.7150/ijbs.19398. eCollection 2017. Int J Biol Sci. 2017. PMID: 28656005 Free PMC article.

2

Tumor-Derived Tissue Factor Aberrantly Activates Complement and Facilitates Lung Tumor Progression via Recruitment of Myeloid-Derived Suppressor Cells.

Han X, Zha H, Yang F, Guo B, Zhu B. Han X, et al. Among authors: zha h. Int J Mol Sci. 2017 Jan 19;18(1):22. doi: 10.3390/ijms18010022. Int J Mol Sci. 2017. PMID: 28106852 Free PMC article.

3

Blocking C5aR signaling promotes the anti-tumor efficacy of PD-1/PD-L1 blockade.

Zha H, Han X, Zhu Y, Yang F, Li Y, Li Q, Guo B, Zhu B. Zha H, et al. Oncoimmunology. 2017 Jul 13;6(10):e1349587. doi: 10.1080/2162402X.2017.1349587. eCollection 2017. Oncoimmunology. 2017. PMID: 29123963 Free PMC article.

4

Control of Intestinal Inflammation, Colitis-Associated Tumorigenesis, and Macrophage Polarization by Fibrinogen-Like Protein 2.

Zhu Y, Zhou J, Feng Y, Chen L, Zhang L, Yang F, Zha H, Wang X, Han X, Shu C, Wan YY, Li QJ, Guo B, Zhu B. Zhu Y, et al. Among authors: zha h. Front Immunol. 2018 Jan 30;9:87. doi: 10.3389/fimmu.2018.00087. eCollection 2018. Front Immunol. 2018. PMID: 29441068 Free PMC article.

5

Intracellular Activation of Complement C3 Leads to PD-L1 Antibody Treatment Resistance by Modulating Tumor-Associated Macrophages.

Zha H, Wang X, Zhu Y, Chen D, Han X, Yang F, Gao J, Hu C, Shu C, Feng Y, Tan Y, Zhang J, Li Y, Wan YY, Guo B, Zhu B. Zha H, et al. Cancer Immunol Res. 2019 Feb;7(2):193-207. doi: 10.1158/2326-6066.CIR-18-0272. Epub 2018 Dec 4. Cancer Immunol Res. 2019. PMID: 30514794

6

Centromere protein U expression promotes non-small-cell lung cancer cell proliferation through FOXM1 and predicts poor survival.

Wang X, Chen D, Gao J, Long H, Zha H, Zhang A, Shu C, Zhou L, Yang F, Zhu B, Wu W. Wang X, et al. Among authors: zha h. Cancer Manag Res. 2018 Dec 14;10:6971-6984. doi: 10.2147/CMAR.S182852. eCollection 2018. Cancer Manag Res. 2018. PMID: 30588102 Free PMC article.

7

C3a-C3aR signaling promotes breast cancer lung metastasis via modulating carcinoma associated fibroblasts.

Shu C, Zha H, Long H, Wang X, Yang F, Gao J, Hu C, Zhou L, Guo B, Zhu B. Shu C, et al. Among authors: zha h. J Exp Clin Cancer Res. 2020 Jan 13;39(1):11. doi: 10.1186/s13046-019-1515-2. J Exp Clin Cancer Res. 2020. PMID: 31931851 Free PMC article.

8

Non-canonical PD-1 signaling in cancer and its potential implications in clinic.

Zha H, Jiang Y, Wang X, Shang J, Wang N, Yu L, Zhao W, Li Z, An J, Zhang X, Chen H, Zhu B, Li Z. Zha H, et al. J Immunother Cancer. 2021 Feb;9(2):e001230. doi: 10.1136/jitc-2020-001230. J Immunother Cancer. 2021. PMID: 33593825 Free PMC article. Review.

9

CD200⁺ cytotoxic T lymphocytes in the tumor microenvironment are crucial for efficacious anti-PD-1/PD-L1 therapy.

Wang X, Zha H, Wu W, Yuan T, Xie S, Jin Z, Long H, Yang F, Wang Z, Zhang A, Gao J, Jiang Y, Wang L, Hu C, Wan YY, Li QJ, Symonds ALJ, Jia Q, Zhu B. Wang X, et al. Among authors: zha h. Sci Transl Med. 2023 Jan 18;15(679):eabn5029. doi: 10.1126/scitranslmed.abn5029. Epub 2023 Jan 18. Sci Transl Med. 2023. PMID: 36652534

10

Circulating T cells: a promising biomarker of anti-PD-(L)1 therapy.

Hou J, Yang X, Xie S, Zhu B, Zha H. Hou J, et al. Among authors: zha h. Front Immunol. 2024 Mar 21;15:1371559. doi: 10.3389/fimmu.2024.1371559. eCollection 2024. Front Immunol. 2024. PMID: 38576625 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

313 results

Search Page

Filters